Metagenomi Therapeutics, Inc. (MGX) Net income 2023–2025
Metagenomi Therapeutics, Inc. (MGX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$87.9MFY2025 · since FY2023: -$68.3M → -$87.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$87.9M | -12.6% |
| FY2024 | -$78.1M | -14.4% |
| FY2023 | -$68.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice